These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 291947

  • 21. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.
    Fernandez HN, Hugli TE.
    J Biol Chem; 1978 Oct 10; 253(19):6955-64. PubMed ID: 690134
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.
    Wagner JL, Hugli TE.
    Anal Biochem; 1984 Jan 10; 136(1):75-88. PubMed ID: 6711816
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Human C5a des Arg increases vascular permeability.
    José PJ, Forrest MJ, Williams TJ.
    J Immunol; 1981 Dec 10; 127(6):2376-80. PubMed ID: 6170701
    [Abstract] [Full Text] [Related]

  • 33. Plasma anaphylatoxin concentrations in inflammatory skin diseases.
    Terui T, Takematsu H, Kato T, Ohkohchi K, Tagami H.
    Tohoku J Exp Med; 1987 Feb 10; 151(2):245-52. PubMed ID: 3495048
    [Abstract] [Full Text] [Related]

  • 34. Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.
    Smith MA, Gerrie LM, Dunbar B, Fothergill JE.
    Biochem J; 1982 Nov 01; 207(2):253-60. PubMed ID: 6760852
    [Abstract] [Full Text] [Related]

  • 35. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J, Damerau B, Vogt W.
    Agents Actions; 1982 Apr 01; 12(1-2):118-21. PubMed ID: 6177210
    [Abstract] [Full Text] [Related]

  • 36. Anaphylatoxin levels in human vitreous humor.
    Mondino BJ, Sidikaro Y, Sumner H.
    Invest Ophthalmol Vis Sci; 1988 Jul 01; 29(7):1195-8. PubMed ID: 3262096
    [Abstract] [Full Text] [Related]

  • 37. Anaphylatoxin generation in multisystem organ failure.
    Heideman M, Hugli TE.
    J Trauma; 1984 Dec 01; 24(12):1038-43. PubMed ID: 6334754
    [Abstract] [Full Text] [Related]

  • 38. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S, Glovsky MM.
    J Allergy Clin Immunol; 1987 Jul 01; 80(1):24-32. PubMed ID: 3496373
    [Abstract] [Full Text] [Related]

  • 39. Effects of human anaphylatoxins on guinea pig atria.
    Huey R, Bloor CM, Hugli TE.
    Immunopharmacology; 1984 Dec 01; 8(3-4):147-54. PubMed ID: 6335143
    [Abstract] [Full Text] [Related]

  • 40. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA, Steiger G, Paccaud JP.
    Clin Exp Immunol; 1986 May 01; 64(2):407-14. PubMed ID: 3488858
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.